CHI Logo
Shop
Checkout
Header Graphic
August 7, 2008
| Insight Pharma Reports > Therapeutic Pipelines And Disease Markets

Add to Del.icio.us Add to furl Add to digg Add to Connotea EMail Page Printer Friendly Book Mark

Therapeutic Pipelines & Disease Markets

Antibiotic R&D: Resolving the Paradox between Unmet Medical Need and Commercial Incentive
July 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Blood-Brain Barrier: Bridging Options for Drug Discovery & Development
May 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Cardiotoxicity: Issues, Technologies, and Solutions for the Future
May 2008
Table of Contents | Tables and Figures | Executive Summary

Inflammatory Directions: Strategies for Six Diseases with Unmet Needs
April 2008
Table of Contents | Tables and Figures | Executive Summary

Monoclonal Antibodies: Pipeline Analysis and Market Assessment
October 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Combination Drug/Diagnostic Products: Pathways to R&D and Commercial Success
May 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Diabetes and Its Complications: Strategies to Advance Therapy and Optimize R&D
May 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Metabolic and Inflammatory Disease R&D : An Assessment of 5 Highly Promising Therapeutic Classes
April 2007
Table of Contents | Tables and Figures | Executive Summary

Cytokine Therapeutics: A Vibrant Pipeline and Active Approved Market
February 2007
Table of Contents | Tables and Figures | Executive Summary

Cancer Immunotherapies and Vaccines: Pipeline Analysis and Competitive Dynamics
November 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Specialty Pharmaceuticals: Driving Industry Growth into the Next Decade
October 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Potential Breakthroughs in Neurotherapeutics: Alzheimer's Disease, Parkinson's Disease, Depression, Bipolar Disorder, and Schizophrenia
October 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Infectious Diseases: R&D Challenges and Market Drivers
September 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Antiviral Therapeutics: Pipelines and Competitive Dynamics
July 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Emerging Targets in Diseases with High Unmet Need: Alzheimer's Disease, Lung Cancer, Dyslipidemia, Type 2 Diabetes, and COPD
June 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Kinase Therapeutics: A Wealth of Targets Sparks a Highly Active Market
May 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Oncogenomics: The Future of Cancer Cure
January 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

RNAi Therapeutics: Challenges in Drug Development and Delivery
November 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Hematological Cancer Therapeutics: Pipelines and Competition
October 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Combination Therapies: Benefits and Challenges in Drug, Device, and Biologicals Development
August 2005
Table of Contents | Tables and Figures | Executive Summary

Inflammatory Disease Therapeutics: Pipelines
June 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary